Executive Medical Director, Clinical Development, Solid Tumors

The Senior/Executive Medical Director, Clinical Development, Solid Tumors will be responsible for driving the global clinical development strategy in solid tumors, specifically Stemline’s Breast Cancer product, Elecestrant. The incumbent will be responsible for providing critical input into the strategy, development, management, and implementation of Phase 1-4 clinical studies by closely working with the Clin Ops colleagues; leading multi-disciplinary teams charged with guiding clinical development and subsequent regulatory submissions. This includes responsibility for the design and execution of first-in-human through registration-enabling studies.   - Represent the clinical science line function on global...